Friday 20 Jun, 2025 03:06 PM
Site map | Locate Us | Login
   Krishival Foods jumps 19% in four days    Sai Life Sciences rises on completion of second phase expansion at Bidar facility    Jaykay Enterprises Ltd leads losers in 'B' group    Volumes jump at Endurance Technologies Ltd counter    NTPC Green surges after India Ratings assigns 'AAA/A1+' rating to debt facilities with 'stable' outlook    Nestle India rises on bonus issue plan    Tamilnad Mercantile Bank trims lending rate by 50 bps; RLLR now at 8.50%    Mahindra & Mahindra Ltd spurts 2.69%, rises for third straight session    HDFC Bank Ltd spurts 1.08%, rises for third straight session    Sun TV slips on buzz of Maran family feud    AXISCADES Tech gains after inking MoU for defense systems production with Indra    Kakatiya Cement Sugar & Industries Ltd leads gainers in 'B' group    PFC, REC gain as RBI unveils final project finance norms    Endurance Technologies Ltd leads gainers in 'A' group    Dilip Buildcon gains on bagging Rs 1,341-cr tunnel project from KRCL 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Natco Pharma receives seven observations from USFDA Following Inspection at Kothur Facility
20-Jun-25   09:54 Hrs IST

In a regulatory filing, the company stated that the USFDA conducted the inspection from 9 June to 19 June 2025. At the conclusion of inspection, the USFDA has issued a Form 483 with seven observations.

Natco Pharma expressed confidence in addressing the observations within the stipulated timeline and reaffirmed its commitment to current Good Manufacturing Practices (cGMP) and the consistent supply of high-quality pharmaceutical products to global markets.

NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products.

The company's consolidated net profit increased 5.3% to Rs 406.60 crore on a 14.3% jump in revenue from operations to Rs 1,221 crore in Q4 FY25 over Q4 FY24.

The counter shed 0.98% to Rs 872.75 on the BSE.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 42083444
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited